Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors

NCT00756847 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Non-Small Cell Lung Cancer
Endometrial Carcinoma
Ovarian Carcinoma

Interventions

DRUG: XL147 (SAR245408),
DRUG: paclitaxel
DRUG: carboplatin

Sponsor

Sanofi